24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publication dates

All regions

Lymphoma Industry, November 2014 Market Reports from Top Publishers

You might be interested in: Flow Cytometry, Hematology, Cancer, more »


 
1-20 of about 8 900 reports for Lymphoma

Janssen-Cilag SpA SWOT Analysis, Strategy, Revenues and Profits

Janssen-Cilag SpA SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Pulmonary fibrosis (ipf) and sarcoidosis. The company develops drugs for breast and ovary cancer, prostate cancer, the lymphomas and acute myeloid leukemia. It operates a subsidiary of johnson and johnson ...

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Key elements such as swot analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. The leukemia & lymphoma society, inc. - Strategic swot ...

EpiZyme, Inc. (EPZM) - Financial and Strategic SWOT Analysis Review

EpiZyme, Inc. (EPZM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Modifying enzymes, and others. The company partners with celgene, glaxosmithkline, eisai, the leukemia & lymphoma society and multiple myeloma research foundation. Epizyme is headquartered in cambridge, massachusetts ...

Lymphoma Drug Pathway Analyzer 2014

Lymphoma Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

... Before. Its capabilities moves you beyond powerful competitive intelligence to an opportunity seeking tool which lets you, by means of both present and emerging scientific knowledge, analyze the lymphoma ...

 Hodgkin Lymphoma-API Insights, 2014

Hodgkin Lymphoma-API Insights, 2014

  • $ 1 250
  • Industry report
  • November 2014
  • by Delve Insight

... Evaluate the marketing status and exclusivity details of hodgkin lymphoma key products to exploit opportunities for generic drug development opportunities. - Key players in the pharmaceutical industry ...

 Lymphoma-API Insights, 2014

Lymphoma-API Insights, 2014

  • $ 1 250
  • Industry report
  • November 2014
  • by Delve Insight

... Opportunities and challenges are identified. - Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to lymphoma ...

 Non-Hodgkin Lymphoma-API Insights, 2014

Non-Hodgkin Lymphoma-API Insights, 2014

  • $ 1 250
  • Industry report
  • November 2014
  • by Delve Insight

... Markets such as india and china.Delveinsight's, non-hodgkin lymphoma -api insights, 2014 report describes the current therapeutics that are propelling the pharmaceutical markets worldwide ...

Lymphoma Partnering 2009-2014

Lymphoma Partnering 2009-2014

  • $ 995
  • Industry report
  • November 2014
  • by Currentpartnering

... Links to online copies of actual lymphoma deals and contract documents as submitted to the securities exchange commission by companies and their partners, where available. Contract documents provide ...

Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options

Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options

  • $ 4 995
  • Industry report
  • October 2014
  • by GBI Research

... Of indications of several already marketed drugs such as revlimid as a maintenance therapy for dlbcl, velcade as a front-line therapy for mcl and adcetris as front-line therapy for cd30 t-cell lymphoma, will fuel ...

Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2014

Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

... T-cell lymphoma pipeline on the basis of target, moa, route of administration and molecule type- latest news and deals relating related to pipeline productsreasons to buy ...

About 1 200 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • Facts Spring 2014
  • April 2014
    28 pages
  • Cancer  

  • United States  

    North America  

View report >

22 Companies for Lymphoma

Read our Company Profiles

Celgene Corp.

United States

Novartis Inc.

Switzerland

Pharmacyclics Inc.

United States

Bristol-Myers Squibb Co.

United States

Seattle Genetics Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.